Curated News
By: NewsRamp Editorial Staff
September 24, 2026
SS Innovations Launches Robotic Cardiac Surgery Program in India
TLDR
- SS Innovations installed 238 SSi Mantra systems, up 42 percent, and now enters 12 countries with robotic cardiac surgery.
- The SSi Mantra 3.0 system enables robotic LIMA take-down for cardiac surgery, performed by Dr. Singh at HCG Hospital.
- Robotic cardiac surgery at HCG Hospital in Ahmedabad expands access to advanced care, improving patient outcomes in the region.
- SS Innovations launched a robotic cardiac surgery program at HCG Hospital in Ahmedabad using the SSi Mantra 3.0 system.
Impact - Why it Matters
This news matters because it highlights the growing adoption of robotic-assisted surgery in emerging markets, potentially improving patient outcomes and access to minimally invasive procedures. SS Innovations' expansion into 12 countries and its pursuit of FDA and CE marking signal a broader trend toward globalization of advanced medical technologies. For investors, the 42% increase in system installations demonstrates strong commercial traction, positioning SSII as a key player in the competitive surgical robotics market. As robotic surgery becomes more prevalent, it could lead to shorter recovery times, reduced complications, and more precise operations, ultimately benefiting patients worldwide.
Summary
SS Innovations International (NASDAQ: SSII), a developer of innovative surgical robotic technologies, has expanded the clinical footprint of its SSi Mantra surgical robotic system with the launch of a robotic cardiac surgery program at HCG Hospital in Ahmedabad, India. The program began with a robotic left internal mammary artery (LIMA) take-down performed by Dr. Brajmohan Singh and proctored by Dr. Lalit Malik, using the SSi Mantra 3.0 system. The company congratulated the team in a LinkedIn post, expressing gratitude for their trust and commitment to advancing robotic cardiac surgery in the region.
This milestone comes as SS Innovations reports significant growth, with 238 SSi Mantra systems installed as of September 8, up 42% from the end of 2025. The system is now installed across 12 countries, with recent expansion into Colombia, Sri Lanka, and the Philippines. SS Innovations is also pursuing U.S. FDA review and European Union CE marking to further expand SSi Mantra into additional international markets. The company remains focused on enabling hospitals worldwide to adopt advanced robotic surgical solutions.
For more details, Read More>>. The latest news and updates relating to SSII are available in the company’s newsroom at https://ibn.fm/SSII. InvestorWire, a specialized communications platform within the IBN Dynamic Brand Portfolio, syndicated this announcement.
Source Statement
This curated news summary relied on content distributed by InvestorBrandNetwork (IBN). Read the original source here, SS Innovations Launches Robotic Cardiac Surgery Program in India
